RecBio
Recbio is a China-based biopharmaceutical company that researches and develops genetically engineered vaccines for diseases such as HPV, tuberculosis and COVID.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed RecBio Information
Geographic Data
Address: Vaccine Engineering Center, China Medical City
City: Taizhou
State: zhejiang province
Zip: 317000
Country: CN
Financial Info
Stage:
series c
Raised Last:
$156M
Raised Total:$382M
Social
Metrics
4,618,713Website Global Rank
1,973Website Monthly Traffic
Twitter Followers
Description
Recbio is a China-based biopharmaceutical company that researches and develops genetically engineered vaccines for diseases such as HPV, tuberculosis and COVID.
Contact Phone:
Contact Email:
RecBio went public on 3/31/2022 on the Hong Kong Stock Exchange
Listed Exchange:
Hong Kong Stock Exchange
IPO Date:
3/31/2022
Ticker Symbol:
2179
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
